The POEM Study has just been published!

Back to NEWS

The recently terminated POEM Study has just been published in the International Journal of Gynecologic Cancer. In this phase 0 study led by Dr. Andrés Poveda of the Instituto Valenciano de Oncología, that was carried out in 5 large centers in Spain, patients with endometrial cancer were treated with 4 doses of temsirolimus prior to surgery. The primary objective was the analysis of paired endometrial aspirates and post-treatment tissue samples for mTOR downstream effectors p-S6K1 and p-4BEP1 levels by immunohistochemistry.

Share (and comment) this content

Back to NEWS